1. Introduction {#sec1}
===============

MicroRNAs (miRNAs) are a family of 20\~25-nucleotide small RNAs that generated from primary miRNA (pri-miRNA) transcribed by RNA polymerase II (Pol II). In the nucleus, the RNase III endonuclease Drosha and the double-stranded RNA-binding domain (dSRBD) protein DGCR8/Pasha cut one strand of the stem of the pri-miRNA hairpin and liberate a \~70-nucleotide stem-loop called a "pre-miRNA." Exportin-5 transports the pre-miRNA into the cytoplasm and Dicer cuts pre-miRNA, together with the dSRBD protein TRBP/Loquacious, to generate the miRNA duplex. The miRNA strand is loaded into an Argonaute-containing RNA-induced silencing complex (RISC), which recognizes target mRNAs and commonly results in translational inhibition or destabilization of the target mRNA \[[@B1]--[@B3]\]. Up to now, miRNAs have been well documented as critical regulator in the development of tissues and organs and the pathogenesis of clinical diseases \[[@B4], [@B5]\].

The microRNA-30 (miR-30) family is an important member of miRNA family, which contains five members and 6 mature miRNA molecules (namely, miR-30a, miR-30b, miR-30c-1, miR-30c-2, miR-30d, and miR-30e) and is encoded by six genes located on human chromosome 1, 6, and 8 ([Figure 1](#fig1){ref-type="fig"}). These mature miRNAs share a common seed sequence near the 5′ end but possess different compensatory sequences near the 3′ end ([Table 1](#tab1){ref-type="table"}). These different compensatory sequences allow miR-30 family members to target different genes and pathways, thus performing corresponding biological function \[[@B6]\]. Recent studies have shown that miRNA-30 family played an important regulatory role in tissues and organs development, as well as related clinical diseases pathogenesis.

2. miR-30 Family and Tissue and Organ Development {#sec2}
=================================================

2.1. miR-30 Family and Bone Tissue {#sec2.1}
----------------------------------

As early as in 2008, Li et al. reported that the expression of miR-30a and miR-30d decreased significantly in the differentiation of mesenchymal stem cell C2C12 induced by bone morphogenetic protein-2 (BMP-2) \[[@B7]\]. Subsequently, Wu et al. further discovered that miR-30 family members (including miR-30a, miR-30b, miR-30c, and miR-30d) could target transcription signaling molecule SMAD family member 1 (Smad1) and runt-related transcription factor 2 (Runx2) and negatively regulated BMP-2-induced differentiation of osteoblastic cells. However, the expression of miR-30e did not change in osteoblastic cells with BMP-2 stimulation, indicating that miR-30 family played an important role in osteoblast differentiation, but the exact roles of distinct miR-30 family members during osteogenic differentiation might be different \[[@B8]\]. In addition, Zhang et al. found that, with the stimulation of bone morphogenetic protein-9 (BMP-9), mesenchymal stem cell C3H10T1/2 could differentiate into osteoblastic cells. In this process, miR-30a played an important negative regulatory role. In detail, the expression of miR-30a in BMP-9-stimulated MSCs decreased at early stage and then increased at late stage of osteogenic differentiation. Moreover, miR-30a overexpression could affect the proliferation of MSCs, leading to a reduction in the expression of early osteogenesis marker Runx2 and late osteogenesis marker osteopontin. The mechanism may be related to the altered expression of Runx2, which was regulated by miR-30a \[[@B9]\]. Finally, other literatures also have documented that the expression of miR-30 family members, such as miR-30d and miR-30e, has also changed during the differentiation of MSCs into osteoblastic cells \[[@B10]\]. In conclusion, these studies suggested that miR-30 family participated in bone development. However, the exact role of miR-30 family and its mechanism in promoting embryonic bone formation remain to be elucidated in following studies.

2.2. miR-30 Family and Reproductive System {#sec2.2}
------------------------------------------

miR-30 was reported to be highly expressed in both mouse and human testes tissue and associated with the Homeobox protein and Zn transport, which were critical for male fertility \[[@B11]\], indicating that miR-30 played a role in reproductive development. Fischer et al. further showed that miR-30 family could regulate the generation of recombinant proteins in Chinese hamster ovary cells \[[@B12]\]. In terms of the definite mechanism, their latest research found that S-phase kinase related protein 2 (Skp2) and ubiquitin-conjugating enzyme E2, J1 (Ubej1) were regulated by miR-30 family in Chinese hamster ovary cells. Their data suggested that miR-30 family could affect the expression of recombinant proteins by regulating ubiquitin E3 ligase-Skp2-induced ubiquitin pathway, thereby affecting the development of reproductive system \[[@B13]\]. In addition, other researchers have found that miR-30 family was also robustly expressed in unfertilized rainbow trout eggs, which provided a new point to control the quality of eggs and early embryo formation of rainbow trout in the future \[[@B14]\]. The above studies showed that miR-30 family was involved in the animal reproductive system development, but their role in the development of human reproductive system and the underlying mechanism required further investigation.

2.3. miR-30 Family and Adipogenesis {#sec2.3}
-----------------------------------

Recent studies have found that miR-30 family played an important role in adipocyte differentiation. The expression of miR-30 family members vigorously increased in the differentiation of human adipose tissue-derived stem cells into adipocytes \[[@B15]\]. Moreover, the inhibition of miR-30 family members (including miR-30a and miR-30d) could reduce the process of lipogenesis. Conversely, the overexpression of miR-30 family members could promote the process of lipogenesis. The corresponding mechanism may be related to the expression of the transcription factor Runx2, which was a target of miR-30 family \[[@B16]\]. In addition, Hu et al. found that the expression of miR-30 family members (including miR-30b and miR-30c) was upregulated during adipose differentiation. Moreover, forced expression of miR-30b/c also significantly increased thermogenic gene expression in primary adipocytes. Mechanistic aspect, the knockdown of miR-30 family members (including miR-30b and miR-30c), could inhibit the expression of uncoupling protein 1 (UCP1) and cell death-inducing DFFA-like effector a (Cidea) in brown adipocytes, which was related to upregulation of their target RIP140 \[[@B17]\]. Finally, in an*in vivo*study, Li et al. found an increased expression of miR-30e in animal adipose tissue by using Solexa sequencing \[[@B18]\]. In summary, miR-30 family not only played an important role in adipogenesis but also participated in the regulation of brown adipose tissue function, indicating that it may be a new potential target for regulating lipid metabolism.

2.4. miR-30 Family and the Development of Other Normal Tissues and Organs {#sec2.4}
-------------------------------------------------------------------------

Multiple studies have suggested that miR-30 family members were involved in the development of other tissues and organs, including pancreas, blood vessels, and intestinal tissues, which showed the extensive roles of miR-30 family. For instance, Joglekar found that the concentration of miR-30 family was high in human islets and miR-30 family had participated in the intracellular response of pancreatic epithelial cells through regulating relative signaling pathways in epithelial mesenchymal transition (EMT) \[[@B19]\]. Bridge et al. found that miR-30 family members (including miR-30b and miR-30c) have taken part in the endothelial cell growth process by regulating the expression of *δ*-like ligand 4 (DLL4) during angiogenesis \[[@B20]\]. Moreover, Peck et al. reported that the inhibition of miR-30 family in intestinal epithelial cells resulted in a significant decrease in cell proliferation and a significant increase in the differentiation, indicating that miR-30 family had an important regulatory role in this differentiation process \[[@B21]\]. Finally, there were other studies indicating that miR-30b was also involved in mammary gland development and the expression of miR-30b was related to the lactation and involution \[[@B22]\]. Overall, these findings suggested that miR-30 family might take part in the development of multiple tissues and organs; however, the exact mechanisms need to be further elucidated.

3. miR-30 Family and Clinical Diseases {#sec3}
======================================

3.1. miR-30 Family and Cancer {#sec3.1}
-----------------------------

### 3.1.1. miR-30 Family as Tumor Suppressor miRNAs {#sec3.1.1}

Current studies have shown that miR-30 family, as tumor suppressor, played important roles in the development of various cancers. For example, Cheng et al. found that miR-30a could inhibit the metastasis and invasion of breast cancer cells by negatively regulating the expression of the vimentin \[[@B23]\]. And Braun et al. reported that miR-30 could reduce the invasive potential of mesenchymal anaplastic thyroid carcinoma-derived cells \[[@B24]\]. Consistently, Zhong et al. reported that the inhibition of miR-30c promoted the invasion of non-small cell lung cancer by promoting EMT process \[[@B25]\]. Furthermore, recent studies have found that miR-30 family could inhibit tumor cell growth, which was related to the change of tumor cell autophagy. For example, Singh et al. found that the restoration of miR-30a weakened the tumorigenesis of medulloblastoma cells, accompanied with a decreased expression in Beclin 1 and the inhibition of autophagy \[[@B26]\]. Moreover, Zhang et al. found that miR-30d could inhibit autophagy of colon cancer cells by directly targeting messenger RNA of autophagy related protein 5 (ATG5), Beclin 1, and phosphoinositide 3-kinase (PI3K), thereby promoting cell apoptosis \[[@B27]\].

### 3.1.2. miR-30 Family as Oncogenic miRNAs {#sec3.1.2}

Similar to other miRNAs, such as miR-7 \[[@B28]\], miR-30 family also played a role, as oncogenic miRNA, in tumorigenesis of some cancers, which reflected the complexities of their biological function. For example, Wang et al. found that the overexpression of miR-30a promoted tumor formation by inhibiting the expression of forkhead box protein L2 (FOXL2) in COV434 cells, accompanied with the upregulation of B-cell lymphoma 2 related protein A1 (BCL2A1), immediate early response 3 (IER3), and cyclin D2 \[[@B29]\]. Moreover, the level of miR-30a was upregulated in the urine of ovarian serous adenocarcinoma patients \[[@B30]\]. Consistently, knockdown of miR-30a suppressed the malignant phenotypes of ovarian cancer cells*in vitro* \[[@B30]\]. Most interestingly, Gaziel-Sovran et al. further found that miR-30 family members (including miR-30b and miR-30d) promoted the metastatic behavior of melanoma cells by directly targeting the N-acetyl galactose (GalNAc) transferase GALNT7, resulting in increased synthesis of the immunosuppressive cytokine interleukin-10 (IL-10) and decreased immune cells activation and recruitment \[[@B31]\]. This research work suggested that miR-30 family could contribute to the development of cancer partially through affecting host immune reaction.

In summary, to the contradictory roles of miR-30 family in tumorigenesis, we infer that this may reflect the biological function of miR-30 family, which was related to the different tumor types, the expression level of miR-30 family, and corresponding various target molecules in distinct types of cancers. Therefore, it is necessary to further elucidate the definite function and its mechanism of miR-30 family in related cancers.

3.2. miR-30 Family and Cardiovascular Disease {#sec3.2}
---------------------------------------------

Nakagawa et al. found that the expression of miR-30, which could target cardiac GalNAc-transferase (GALNT) 1 and 2 expression, was abundant in myocardium of healthy hearts but decreased obviously in failing hearts \[[@B32]\]. Furthermore, miR-30e mimic treatment resulted in downregulation of Beclin 1 via inhibiting its 3′UTR activity and protected primary cardiomyocytes against apoptosis*in vitro*. Conversely, miR-30e silencing promoted cardiomyocytes apoptosis by elevating the expression of angiotensin-converting enzyme 2 (ACE2), thereby reducing the apoptosis of cardiomyocytes \[[@B33]\]. However, it would be noticed that, in animal cardiac ischemic injury model, the silence of miR-30 family could elevate the levels of CSE and H~2~S and protect cardiomyocytes against hypoxia-induced injury*in vivo*, indicating the promising therapeutic potential of miR-30 family in ischemic heart diseases \[[@B34]\]. Thus, to this phenomenon, we presume that the controversial finding might be related to the difference on*in vitro* and*in vivo* experimental setting.

In addition, Zhang et al. found that high fat-induced miR-30 upregulation could impair the protective effects of endothelial cell autophagy against atherosclerosis through suppressing protein translation of ATG6 \[[@B35]\]. Finally, other studies showed that miR-30a could downregulate endothelial DLL4 expression, thereby controlling the behavior of tip cells, indicating that miR-30 family was also related to the rarefaction process and hypertension \[[@B36]\]. Hence, the investigation of miR-30 family is much helpful for the illustration on the pathogenesis and the development of novel therapeutic strategies of cardiovascular diseases.

3.3. miR-30 Family and Renal Disease {#sec3.3}
------------------------------------

miR-30 family members are also involved in the pathological process of renal diseases \[[@B37]\]. For example, Wu et al. found that glucocorticoid-sustained miR-30 expression was associated with reduced Notch1 activation and alleviated podocytes damage, accompanied with altered expression of Notch1 and p53 \[[@B38]\], indicating the important role of miR-30 family in renal diseases. In line with this finding, Wu et al. further found that some critical components of calcium/calcineurin signaling, including TRPC6, PPP3CA, PPP3CB, PPP3R1, and NFATC3, were the targets of miR-30 family. Moreover, podocyte-specific expression of the miR-30 sponge in mice increased calcium/calcineurin pathway component protein expression and calcineurin activity \[[@B39]\]. Notably, recent evidence further showed that transforming growth factor-*β* (TGF-*β*) could inhibit the expression of miR-30d through a Smad2/3-HDAC3-NcoR repression complex and provide new insights into a potential target for the treatment of podocytes injury-associated glomerulopathies \[[@B40]\]. In addition, it has been reported that the levels of miR-30 family members (including miR-30a, miR-30c, and miR-30e) increased in the plasma of contrast-induced nephropathy (CIN) rats compared with their levels in non-CIN control rats, suggesting that miR-30 family might serve as early biomarkers and target candidates for CIN \[[@B41]\]. Moreover, miR-30c was also involved in the regulation of renal tubular cell apoptosis in cisplatin-induced nephrotoxicity, which provided a new therapeutic strategy for the improvement of cisplatin-induced nephrotoxicity \[[@B42]\].

Combining these studies suggested that miR-30 family played an important regulatory role in the pathogenesis of various kidney diseases and may be a potential target for treatment and diagnosis of relative diseases.

3.4. miR-30 Family and Other Clinical Diseases {#sec3.4}
----------------------------------------------

Up to now, a large number of studies have demonstrated that miR-30 family has been involved in the pathogenesis of many other diseases, such as osteoarthritis, fibrosis, and hepatitis \[[@B43]\]. For example, Li et al. found that miR-30b was involved in the pathogenesis of osteoarthritis and its expression level in the articular cartilage increased robustly compared with normal people \[[@B44]\]. As for fibrosis diseases, Tu et al. reported that miR-30 could inhibit the occurrence of liver fibrosis, potentially through inhibiting its target molecule TGF-*β* \[[@B45]\]. Berschneider et al. further found that miR-30a could reverse WNT1-induced signaling pathway protein 1 (WISP1) mRNA expression in lung fibrosis, thereby affecting the process of lung fibrosis \[[@B46]\]. Importantly, miR-30 family was also reported to be involved in immune responses and related diseases. For example, miR-30a exhibited low expression in*Mycobacterium tuberculosis*- (MTB-) infected patients and the overexpression of miR-30 suppressed the ability of host cells to eradicate intracellular MTB \[[@B47]\]. Interestingly, the most recent evidence further showed that, in uninfected THP-1 cells, miR-30a could inhibit the expression of myeloid differentiation factor 88 (MyD88) and subsequently reduced the TLR signaling and cytokine expression, indicating that miR-30a participated in MTB-induced immune responses via regulating TLR/MyD88 activation and cytokine expression \[[@B48]\]. Besides, other studies have also found that miR-30 family was related to the pathogenesis of other diseases such as allergic rhinitis \[[@B49]\] and Alzheimer\'s disease \[[@B50]\]. However, the related mechanisms remain to be elucidated.

4. Conclusion {#sec4}
=============

Current studies have shown that miR-30 family, as a member of miRNA family, played an important and promising role in the development of tissues and organs and various clinical diseases. Although existent investigations have revealed the related molecular mechanisms ([Table 2](#tab2){ref-type="table"}), there are still many critical problems that need to be further illustrated in the future, such as (a) how to explore the exact mechanism of distinct miR-30 family members on regulating the development of different tissues and organs, (b) what are the exact roles of miR-30 family members in different types of tumors, (c) how to utilize the difference of miR-30 family members to perform subsequent targeted treatment, and (d) what are the exact roles of miR-30 family members in immune organs development and diseases-related immune responses. We believe that the elucidation of these representative questions not only will help to deepen the understanding of the biological function of miR-30 family but also will bring about a novel insight into diagnosis and molecular targeted therapy of related clinical diseases.
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###### 

The sequences of miR-30 family members.

  miRNAs                                     Pre-miRNA sequences                                                                                    Mature miRNA sequences
  ------------------------------------------ ------------------------------------------------------------------------------------------------------ -------------------------------------------
  miR-30a                                    5\'-GCGACUGUAAACAUCCUCGACUGGAAGCUGUGAAGCCACAGAUGGGCUUUCAGUCGGAUGUUUGCAGCUGC-3\'                        Has-miR-30a-5p: UGUAAACAUCCUCGACUGGAAG
  Has-miR-30a-3p: CUUUCAGUCGGAUGUUUGCAGC                                                                                                            
  miR-30b                                    5\'-ACCAAGUUUCAGUUCAUGUAAACAUCCUACACUCAGCUGUAAUACAUGGAUUGGCUGGGAGGUGGAUGUUUACUUCAGCUGACUUGGA-3\'       Has-miR-30b-5p: UGUAAACAUCCUACACUCAGCU
  Has-miR-30b-3p: CUGGGAGGUGGAUGUUUACUUC                                                                                                            
  miR-30c-1                                  5\'-ACCAUGCUGUAGUGUGUGUAAACAUCCUACACUCUCAGCUGUGAGCUCAAGGUGGCUGGGAGAGGGUUGUUUACUCCUUCUGCCAUGGA-3\'      Has-miR-30c-1-5p: UGUAAACAUCCUACACUCUCAGC
  Has-miR-30c-1-3p: CUGGGAGAGGGUUGUUUACUCC                                                                                                          
  miR-30c-2                                  5\'-AGAUACUGUAAACAUCCUACACUCUCAGCUGUGGAAAGUAAGAAAGCUGGGAGAAGGCUGUUUACUCUUUCU-3\'                       Has-miR-30c-2-5p: UGUAAACAUCCUACACUCUCAGC
  Has-miR-30c-2-3p: CUGGGAGAAGGCUGUUUACUCU                                                                                                          
  miR-30d                                    5\'-GUUGUUGUAAACAUCCCCGACUGGAAGCUGUAAGACACAGCUAAGCUUUCAGUCAGAUGUUUGCUGCUAC-3\'                         Has-miR-30d-5p: UGUAAACAUCCCCGACUGGAAG
  Has-miR-30d-3p: CUUUCAGUCAGAUGUUUGCUGC                                                                                                            
  miR-30e                                    5\'-GGGCAGUCUUUGCUACUGUAAACAUCCUUGACUGGAAGCUGUAAGGUGUUCAGAGGAGCUUUCAGUCGGAUGUUUACAGCGGCAGGCUGCCA-3\'   Has-miR-30e-5p: UGUAAACAUCCUUGACUGGAAG
  Has-miR-30e-3p: CUUUCAGUCGGAUGUUUACAGC                                                                                                            

###### 

The targets of miR-30 family members in tissue and organ development and clinical diseases.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                 Types                                  miRNAs                                     Targets                                               Cells/Models              References
  ------------------------------ -------------------------------------- ------------------------------------------ ----------------------------------------------------- ------------------------- -------------
  Tissue and organ development   Bone tissue                            miR-30a, miR-30d \                         BMP2 \                                                C2C12 cells \             \[[@B7]\] \
                                                                        miR-30a, miR-30b, miR-30c, miR-30d \       Smad1, Runx2  \                                       MC3T3-E1 cells \          \[[@B8]\] \
                                                                        miR-30a,                                    \                                                     \                         \
                                                                                                                   Runx2                                                 C3H10T1/2 cells           \[[@B9]\]

  Reproductive system            miR-30 family                          Skp2, Ubej1                                CHO cells                                             \[[@B13]\]                

  Adipose tissue                 miR-30a, miR-30d                       Runx2                                      hMADS cells                                           \[[@B16]\]                

  miR-30b, miR-30c               UCP1, Cidea, RIP140                    C57BJ6 mice                                \[[@B17]\]                                                                      

  Vessel                         miR-30b, miR-30c                       DLL4                                       LECs, HUVECs                                          \[[@B20]\]                

                                                                                                                                                                                                   

  Related diseases               Tumorigenesis  (as tumor suppressor)   miR-30a                                    Beclin1                                               Daoy, D283, D425 cells    \[[@B26]\] 

  miR-30d                        ATG5, PI3K, Beclin1                    HCT15, HCT116, HT-29, DLD-1, SW480 cells   \[[@B27]\]                                                                      

  Tumorigenesis (as oncogene)    miR-30a                                FOXL2, BCLA1, \                            COV434 cells                                          \[[@B29]\]                
                                                                        IER3, cyclin D2                                                                                                            

  miR-30b, miR-30d               GALNT7                                 Melanoma cells, clinical specimens          \[[@B31]\]                                                                     

  Cardiovascular disease         miR-30e                                ACE2                                       Sprague Dawley rats                                   \[[@B33]\]                

  miR-30                         ATG6                                   ApoE^(-/-)^ mice, HAECs                    \[[@B35]\]                                                                      

  miR-30a                        DLL4                                   Zebrafish                                  \[[@B36]\]                                                                      

  Renal disease                  miR-30 family                          Notch1, p53                                Wistar rats, human podocytes, clinical specimens      \[[@B38]\]                

  miR-30d                        TGF-*β*                                HEK293 cells                               \[[@B40]\]                                                                      

  Osteoarthritis                 miR-30b                                ERG                                        SW1353 cells, clinical specimens                      \[[@B44]\]                

  Hepatic fibrosis               miR-30                                 TGF-*β*                                    ICR mice, HSCs                                        \[[@B45]\]                

  Pulmonary fibrosis             miR-30a                                WISP1                                      Sprague Dawley rats, primary human lung fibroblasts   \[[@B46]\]                

  Tuberculosis                   miR-30a                                MyD88                                      THP-1 cells                                           \[[@B48]\]                

  Radiation damage               miR-30c                                REDD1                                      hFOB cells, CD34^+^ cells                             \[[@B51]\]                

  miR-30b, miR-30c               NF-*κ*B                                CD2F1 mice, CD34^+^ cells                  \[[@B52]\]                                                                      

  miR-30b, miR-30c               Mcl-1                                  CD2F1 mice, CD34^+^ cells                  \[[@B53]\]                                                                      
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

** ** *Notes*. *BMP2*: bone morphogenetic protein-2; *Smad1*: SMAD family member 1; *Runx2*: runt-related transcription factor 2; *Skp2*: S-phase kinase related protein 2; *Ubej1*: ubiquitin-conjugating enzyme E2, J1; *UCP1*: uncoupling protein 1; *Cidea*: cell death-inducing DFFA-like effector a; *DLL4*: *δ*-like ligand 4; *ATG5*: autophagy related protein 5; *PI3K*: phosphoinositide 3-kinase; *FOXL2*: forkhead box protein L2; *BCLA1*: B-cell lymphoma 2 related protein A1; *IER3*: immediate early response 3; IL-10: interleukin-10; *ACE2*: angiotensin-converting enzyme 2; *ATG6*: autophagy related protein 6; *TGF-β*: transforming growth factor-*β*; *ERG*: EST-related genes; *WISP1*: WNT1-induced signaling pathway protein 1; *MyD88*: bone marrow differentiation factor 88; *REDD1*: DNA damage inducible transcript 4; *NF-KB*: nuclear factor kappa B; *Mcl-1*: BCL2 family apoptosis regulator.
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